Assessment of effect of L-Carnitine supplement on subclinical LV systolic dysfunction detected by speckletracking echocardiography in patients with ESRD under hemodiylisis
Phase 4
Recruiting
- Conditions
- speckle echoPatients with ESRD under hemodiylisis.
- Registration Number
- IRCT20221128056646N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Left ventricular ejection fraction more than or equal of 50 persent
3 times a weak routine and regular hemodialysis
Agreement to take part in the study
Hemodialysis patient with age more than 18 who start hemodialysis for more than 3 months
If the pateint have been used L-Carnetine supplement before the study,should stop using it for at least 1 weak for entrance to our study
Exclusion Criteria
Pateint who used medicine which make drug intractions with the supplement
Pateints who are pregnant or have Liver Failure , Thyroid dysfunction, Nephrotic syndrome,Cancers, Vasculitis or other inflamatory disease
Disagreement to take part in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ejection fraction is define with the ability of left venticle to pump blood in each haert beat and bring up with percent. Timepoint: Ejection fraction measure in the begining of study and the after 3months of recivining L-Carnitine supplements. Method of measurement: Speckle tracking echocardiography.
- Secondary Outcome Measures
Name Time Method